Yu, Qingtao
Li, Wenzhi
Long, Jieyi
Liang, Ming
Jiang, Lingli
Lin, Xiaoliang
He, Dongqing
Wu, Zhuoyan
Xia, Xiaole https://orcid.org/0009-0005-3992-1194
Funding for this research was provided by:
Tianjin Synthetic Biotechnology Innovation Capacity Improvement Action (TSBICIP-KJGG-012-06)
National Key Research and Development Program of China (2021YFA0910203)
Article History
Received: 18 December 2024
Accepted: 27 February 2025
First Online: 23 March 2025
Declarations
:
: The authors declare no conflict of interest.
: The study was conducted in accordance with the Declaration of Helsinki, and was approved by the Ethics Committee of Guangdong Pharmaceutical University (protocol code gdpulac2022052 and February 28, 2022 approval).